Up­dat­ed: Three big Con­gres­sion­al hear­ings next week to set the tenor on ac­cel­er­at­ed ap­provals, pan­demics, drug prices, and ARPA-H

Two Sen­ate com­mit­tees and a House sub­com­mit­tee will hold hear­ings next week tak­ing on Covid-19, fu­ture pan­demics, the need to low­er drug prices in Medicare, and a new health re­search in­vestor to be known as ARPA-H.

The com­mit­tees will all seek to ad­vance key pri­or­i­ties as drug pric­ing leg­is­la­tion that in­clud­ed Medicare ne­go­ti­a­tions stalled, and then flat-lined when Sen. Joe Manchin dropped his sup­port for a wider bill. Mean­while, Covid-19 funds were pulled from next year’s gov­ern­ment fund­ing bill, which means Tues­day’s hear­ing on a bi­par­ti­san Covid-19 bill to strength­en the US pub­lic health and med­ical pre­pared­ness and re­sponse sys­tems may turn par­ti­san.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER